US Broker Ratings

Cytokinetics (CYTK) Stock Analysis: Unveiling the 40.98% Potential Upside in Biotech

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, continues to capture the attention of investors with its bold strides in muscle activator and inhibitor therapies. With a..

argenx SE (ARGX) Stock Analysis: Exploring 26% Potential Upside Amid Robust Revenue Growth

For investors seeking opportunities in the biotechnology sector, argenx SE (NASDAQ: ARGX) presents a compelling case with its strong market position and promising growth prospects. Based in the Netherlands, this..

Inspire Medical Systems, Inc. (INSP): Stock Analysis Highlights 50% Potential Upside for Investors

Inspire Medical Systems, Inc. (NASDAQ: INSP) is capturing the attention of investors with its innovative medical solutions and significant growth prospects. As a key player in the medical devices industry,..

Baxter International Inc. (BAX) Stock Analysis: Exploring a 15% Potential Upside Amidst Strategic Global Operations

Baxter International Inc. (NYSE: BAX) presents an intriguing investment prospect for those eyeing the healthcare sector, particularly within the medical instruments and supplies industry. With a significant market presence backed..

Option Care Health, Inc. (OPCH) Stock Analysis: A Strong Growth Prospect with a 5.22% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector focusing on home and alternate site infusion services, presents a compelling opportunity for investors seeking growth in..

BrightSpring Health Services, Inc. (BTSG) Stock Analysis: A Healthcare Contender with 8.84% Upside Potential

BrightSpring Health Services, Inc. (BTSG), a significant player in the healthcare sector, is capturing investor attention with its robust business model and a promising price target. With its roots in..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring the Biotech Firm’s 434% Revenue Growth and Future Prospects

Avidity Biosciences, Inc. (NASDAQ: RNA), a pioneering biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to RNA therapeutics. With a market capitalization of $10.93 billion,..

BioNTech SE (BNTX) Stock Analysis: Exploring a 27% Upside Potential Amidst Robust Revenue Growth

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to immunotherapies targeting cancer and infectious diseases. Headquartered in Mainz, Germany,..

TransMedics Group, Inc. (TMDX) Stock Analysis: Riding the Wave of 32% Revenue Growth in the Booming Medical Devices Sector

TransMedics Group, Inc. (NASDAQ: TMDX) has captured the attention of investors with its innovative solutions in the medical devices sector, specifically in the realm of organ transplant therapy. Headquartered in..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring a 160% Potential Upside

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is making waves in the biotechnology sector, catching the attention of investors with its impressive market cap of $2.28 billion and a striking potential upside..

Prestige Consumer Healthcare (PBH) Stock Analysis: Strong Buy Ratings and Nearly 20% Upside Potential

Investors searching for promising opportunities in the healthcare sector might find Prestige Consumer Healthcare Inc. (NYSE: PBH) an intriguing prospect. With a market capitalization of $3.2 billion, Prestige Consumer Healthcare..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unpacking the 173% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), a pioneering player in the biotechnology sector, has captured investor attention with a compelling potential upside of 173.16%, according to analyst ratings. With a market..

Masimo Corporation (MASI) Investor Outlook: Exploring a 29% Potential Upside in the Medical Devices Sector

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, specifically in the medical devices industry, is drawing significant attention from investors. With a market capitalization of $7.63 billion,..

Axsome Therapeutics (AXSM) Stock Analysis: Unpacking the 16.68% Upside Potential and Robust Revenue Growth

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a biopharmaceutical company making significant strides in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $8.94 billion, Axsome is..

Glaukos Corporation (GKOS) Stock Analysis: A Growing Titan in the Healthcare Sector with a 5.88% Upside

Glaukos Corporation (NYSE: GKOS), a leader in the healthcare sector specializing in ophthalmic pharmaceuticals and medical technology, is capturing investor attention with its robust growth trajectory. With a market cap..

Alkermes plc (ALKS)

⚠️ No article content returned.

..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating the Biotech Volatility with a 41.80 RSI Signal

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a compelling player in the healthcare sector, specializing in biotechnology with a focus on genetic therapies for rare diseases. With a market capitalization of..

Genmab A/S (GMAB) Stock Analysis: Unveiling a 17% Upside Potential in the Biotechnology Space

Genmab A/S (NASDAQ: GMAB), a prominent player in the biotechnology sector, is capturing investor attention with its promising portfolio and a substantial potential upside of 17.25%. As a Danish-based company..

Exact Sciences Corporation (EXAS) Stock Analysis: A Healthcare Innovator Nearing Its 52-Week High

Exact Sciences Corporation (NASDAQ: EXAS), a leader in the healthcare diagnostics and research sector, has been making waves with its innovative cancer screening and diagnostic products. As the company reaches..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Unlocking a 13.68% Potential Upside in the Healthcare Sector

Intuitive Surgical, Inc. (ISRG), a titan in the healthcare sector, continues to capture investor attention with its innovative medical instruments and a robust market presence in the minimally invasive surgical..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds